Dr. Mary Teeling
Adjunct Assistant Professor (p/t), Pharmacology & Therapeutics
Biography
I am a specialist pharmaceutical physician with extensive experience in the areas of pharmacology and pharmaceutical medicine. In addition to my role as Assistant Professor, in the School of Medicine, Trinity College Dublin, I also work in the National Medicines Information Centre (NMIC) as a part-time medical advisor. I worked in the national regulatory authority (Irish Medicines Board) for 12 years and served as its medical director from 1995-2000. I was a member of the European scientific committee (Committee for Human Medicinal Products) from 1994-2000 and was appointed to the role of vice-chairman in 1998 until 2000. In my role as medical advisor in the NMIC, I am the co-author of the NMIC publications Therapeutics Today and NMIC Bulletin, which provide updates on therapeutic topics to primary care physicians and other healthcare professionals. I was part of the education team that developed the higher specialist training (HST) programme in Pharmaceutical Medicine, in conjunction with the Royal College of Physicians in Ireland (RCPI). I am currently the National Specialty Director for Pharmaceutical Medicine and a member of the Irish Committee for Higher Medical Training (ICHMT) in RCPI.
Publications and Further Research Outputs
Peer-Reviewed Publications
Teeling M, MacAvin M, Bennett K, Impact of safety warnings on domperidone prescribing in Ireland, Irish Journal of Medical Science, 2017, p5
Cooper JA, Moriarty F, Ryan C, Smith SM, Bennett K, Fahey T, Wallace E, Cahir C, Williams D, Teeling M, Hughes CM., Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria., European Journal of Clinical Pharmacology, 72, (5), 2016, p583 - 591
O'Shea MP, Teeling M, Bennett K., Regional variation in medication-taking behaviour of new users of oral anti-hyperglycaemic therapy in Ireland, Irish Journal of Medical Science, 184, (2), 2015, p403 - 410
O'Shea MP, Teeling M, Bennett K., Comorbidity, health-related quality of life and self-care in type 2 diabetes: a cross-sectional study in an outpatient population., Irish Journal of Medical Science, 184, (3), 2015, p623 - 630
Cooper JA, Ryan C, Smith SM, Wallace E, Bennett K, Cahir C, Williams D, Teeling M, Fahey T, Hughes CM; (The PROMPT Steering Group) , The development of the PROMPT (PRescribing Optimally in Middle-aged People's Treatments) criteria., BMC Health Services Research, 14, 2014, p13
O'Shea MP, Teeling M, Bennett K., An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti-hyperglycaemic agents., Pharmacoepidemiology and Drug Safety, 12, 2013, p1336 - 1344
O'Shea M, Teeling M, Bennett K, The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: A retrospective cross-sectional study using a national pharmacy claims database., BMC health services research, 13, 2013, p23
Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K, , Potentially inappropriate prescribing and cost outcomes for older people: a national population study, British Journal of Clinical Pharmacology, 69, 2010, p542 - 552
M. Teeling, H. O'Connor, J. Feely, K. Bennett, What therapies have replaced rofecoxib in Ireland ?, British Journal of Clinical Pharmacology, 64, (4), 2007, p536 - 541
M. Savage, M. Teeling, K. Bennett, J. Feely, Adherence to clinical guidance in the prescribing of oral antithrombotic medication in patients with atrial fibrillation, Irish Journal of Medical Science, 175, (2), 2006, p46 - 49
M. Teeling, K. Bennett, H. O'Connor, J. Feely, How did the withdrawal of rofecoxib impact on prescribing of non-steroidal anti-inflammatory drugs ?, British Journal of Clinical Pharmacology, 61, 2006, pp637 - 638
M. Teeling, K. Bennett, J. Feely, What therapies have replaced Rofecoxib, Pharmacoepidemiology and Drug Safety, 15, 2006, S46
C. Usher, M. Teeling, K. Bennett, J. Feely, Effect of clinical trial publicity on HRT prescribing in Ireland, European Journal of Clinical Pharmacology, 1, 2006, p4
C. Usher, M. Teeling, K. Bennett, B. McGowan, J. Feely, Usage of paracetamol-containing combination analgesics remains high in primary, British Journal of Clinical Pharmacology, 60, (6), 2005, p648 - 652
M. Savage, M. Teeling, K. Bennett and J. Feely, Adherence to clinical guidance in the prescribing of anticoagulant medication in patients with atrial fibrillation, British Journal of Clinical Pharmacology, 59, 2005, 646
K. Bennett, M. Teeling, J. Feely, Overprescribing antidepressants to children: pharmacoepidemiological study in, British Medical Journal, 331, 2005, p1451 - 1452
Teeling M, Bennett K, Feely J., The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002., British Journal of Clinical Pharmacology, 59, 2005, p227 - 232
M. Teeling, J. Feely, Adverse drug reactions: reducing the risk in older people, Prescriber, 5, 2005, p12 - 19
Teeling M, Bennett K, Feely J. , Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs., British Journal of Clinical Pharmacology, 57, 2004, p337 - 343
M. Teeling, K. Bennett, J. Feely, Have COX 2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs ? , British Journal of Clinical Pharmacology, 55, 2003, 419
Bennett K, Teeling M, Feely J., "Selective" switching from non-selective to selective non-steroidal anti-inflammatory drugs, Eur J Clin Pharmacol., 59, (8-9), 2003, p645 - 649
K. Bennett, M. Teeling and J. Feely, Selective switching from non-selective to selective non-steroidal anti-inflammatory drugs, European Journal of Clinical Pharmacology, 59, (38238), 2003, p645-9
McGing P., Daly R., Teeling M., Kyne F., Carney D.N., Serum TPS (TPA) and CA125 as prognostic markers in ovarian cancer, Proc Nat. Meeting of Assoc. of Clin Biochem., 1994
Teeling M., Hayes Y., Fitzmaurice B., McGing P., Carney D.N., Carboplatin / Cyclophosphamide Combination Chemotherapy for advanced ovarian cancer, Seminars Oncol., 19, (1(Suppl. 2)1), 1992, p102 - 106
Teeling M., Carney D.N., Phase II study of carboplatin and cyclophosphamide combination chemotherapy for the treatment of advanced ovarian cancer, Eur. J of Gynaecol Oncol, 11, (3), 1990, p219 - 224
McGing P.G., Teeling M., McCann A., Kyne F, Carney D.N., Non-MCK - a practical measure of creatinine kinase in cancer patients, Clin Chim Acta, 187, (3), 1990, p309 - 315
Carboplatin plus cyclophosphamide for epithelial ovarian cancer in, editor(s)P.A. Bunn Jr., R., Cannetta, R.F. Ozols, M. Rozencwieg , Carboplatin (JM8) Current perspectives and future directions, W.B. Saunders Company, 1990, [Carney D.N., Teeling M.]
Splinter T.A.W., Carney D.N., Teeling M. Peake M.D., Kho GS, Oosterom R. and Cooper E.J., Neuron-Specific enolase can be used as the sole guide to treat small cell lung cancer patients, J. Cancer Res. Clin. Oncology, 115, (4), 1989, p400 - 401
Teeling M., Carney D., Casey B., Pratt I. and Ryan M.P., Comparison of the effects of cisplatin and carboplatin on magnesium status in cancer patients, Magnesium Research, 2, 1989, p101 - 101
Teeling M, McGing P, Carney DN, The prognostic value of post chemotherapy serum CA 125 in epithelial ovarian cancer, Ir. J. Med. Sci, 58, (3), 1989, p59 - 62
Teeling M., McGing P., Johnston P., Carney D.N., Clinical Correlation of Tumor Endocrine Markers in Lung in cancer, Cancer Treat Res, 45, 1989, p137 - 149
Carney D.N, Teeling M., Neuron-Specific Enolase: How useful as a Cancer Maker?, Eur. J. Cancer Clin. Oncol., 24, (5), 1988, p825 - 828
Splinter TA, Carney DN, Teeling M, Oosterom R., Levels of Neuron-specific enolase after chemotherapy do not predict a response in small cell lung cancer, J. Cancer Res Clin Oncol, 114, (6), 1988, p641 - 643
O'Neill H, Teeling M, Carney DN, Ennis JT., Abdominal computed tomography in patients with small cell lung cancer, Ir. J. Med Sci, 157, (11), 1988, p344 - 347
Biochemical Markers of lung cancer in, editor(s)S. Rosen, J. Mulshine, F. Cuttita, P.G. Abrams , Biology of lung cancer: Diagnosis and Treatment, Marcel Dekker Inc., 1988, [Teeling M. and Carney D.N.]
Burke, E, Teeling M, Carney D, Eustace P., The Retinotoxic Effects of Oncological Agents, Bull Soc. Belge Ophthalmol, 224, 1987, p77 - 79
Teeling M., Carney D.N., Carboplatin and cyclophosphamide combination chemotherapy in advanced ovarian cancer, Proc. Amer Soc. Clin. Oncol., 6, 1987, p458 - 458
Dervan P., Teeling M., Dempsey J., Drury M., Murphy J., O'Malley E. and O'Connell D., Lymphadenopathy due to fatal histiocytic proliferative disorder containing Michaelis-Gutmann Bodies, Cancer, 57, (7), 1986, p1337 - 1340
Teeling M., Casey B., Carney D.N., Pratt I. and Ryan M.P., Differential nephrotoxicity of cisplatin and carboplatin, Clinical Science, 71, (suppl. 15), 1986, p76 - 76
Teeling M., Casey B., Pratt I., Ryan M.P. and Carney D.N., N-acetyl-B-glucosaminidase (B Nag) as an early predictor of renal tubular dysfunction in cisplatin nephrotoxicity, Proc. Am. Soc. Clin Oncol., 5, 1986, p204 - 204
Teeling M., Conlon D., Pratt I., Carney D.N. and Ryan M.P., Prospective investigation of Cisplatin-induced nephrotoxicity including renal magnesium wasting in cancer patients, J. American College Nutrition, 5, 1985, p1489 - 1489
Robinson A.C.R., Teeling M. and Casey E.B., Hepatic function in ankylosing spondylitis, Annals of Rheumatic diseases, 42, (5), 1983, p550 - 552
Robinson A. and Teeling M., Angioneurotic oedema and urticaria induced by hyoscine butyl bromide, Post Graduate Medical Journal, 58, (679), 1982, p316 - 316
Robinson A., Dockery J., Teeling M., Peacock A. and Casey E., Gonococcal arthritis in pregnancy: A report of two cases, Irish Journal of Medical Science, 151, (10), 1982, p313 - 314
Non-Peer-Reviewed Publications
Pharmacovigilance and Risk Management in, editor(s)A C Cartwright, B R Matthews , International Pharmaceutical Product Registration, , United Kingdom, Informa Healthcare, 2009, [Informa Healthcare]
M. Teeling, J. Feely, Prevention of NSAID side effects, Clinical Focus (Forum), 5, (4), 2005, p4 - 6
M. Teeling, K. Bennett, J. Feely, Have COX 2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs ?, British Journal of Clinical Pharmacology, 55, 2004, 419
Teeling M., "Use of Naloxone in the management of Opiate Dependence Syndrome" Report for the National Advisory Committee on Drugs (NACD), Dublin, Stationery Office, Government Publications, 2003
Teeling M., "Use of Lofexidine and Naloxone in the management of Opiate Dependence Syndrome" Report for the National Advisory Committee on Drugs (NACD), Dublin, Stationery Office, Government Publications, 2003
Teeling M., "Use of Buprenorphine as an intervention in the treatment of Opiate Dependence Syndrome" Report for the National Advisory Committee on Drugs (NACD), Dublin, Stationery Office, Government Publications, 2002
Teeling M., Licensing of Vaccines, Forum, 17, (7), 2000, p39 - 41
Teeling M, The European Regulatory Perspective: Scientific Advice, Int J. Pharm Med, 13, 1999, p92 - 92
Teeling M, Immunisation: New developments in vaccines, Modern Medicine, 27, (10), 1997, p67 - 68
Teeling M., Initial Experiences with the New European Regulatory Procedures, J. Eur Soc Reg Affairs, 3, (3), 1996, p53 - 54
Research Expertise
Description
. Clinical Pharmacology . Pharmaceutical Medicine . Clinical Oncology . PharmacoepidemiologyRecognition
Representations
National Specialty Director, Pharmaceutical Medicine, Royal College of Physicians of Ireland.
Vice chairman of the Committee for Proprietary Medicinal Products (CPMP, European Medicines Agency
EU member of the Steering Committee on International Conference on Harmonisation (ICH)
Former chairman of the Scientific Advice Working Party, European Medicines Agency
Former chairman of the CPMP ad hoc committee on anti-cancer agents
Awards and Honours
1999 Outstanding Service Award - Drug Information Association (DIA).
Memberships
Royal Academy of Medicine in Ireland (fellow)
International Society of Pharmacoepidemiology
Association of Pharmaceutical Physicians of Ireland (APPI)
Royal College of Physicians of Ireland (Fellow)